Form D · Biotechnology
Genprex, Inc.
Austin, TX · CIK 0001595248
Offering snapshot reported Nov 22, 2019 · SEC filing
- Reported sold
- $0 Offering amount: $1.46M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 22, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 22, 2019 | Initial | $0 | No comparison | 2 | SEC filing |
| May 23, 2018 | Initial | $10,000,000 | No comparison | 2 | SEC filing |
| Oct 4, 2016 | Initial | $949,971 | No comparison | 1 | SEC filing |
| Mar 4, 2015 | Initial | $160,000 | No comparison | 1 | SEC filing |
| Dec 30, 2013 | Initial | $100,000 | No comparison | 1 | SEC filing |
| Dec 30, 2013 | Initial | $1,400,000 | No comparison | 1 | SEC filing |
| Dec 26, 2013 | Initial | $500,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $88.7K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-354072
Represents an aggregate exercise price of warrants to purchase 3,167,986 shares of common stock which were issued in connection with an offering of 3,167,986 shares of common stock issued in a registered direct offering (the "RDO").
Represents 7% of the gross proceeds from the sale of securities in the RDO and concurrent private placement of warrants. Excludes reimbursement of legal expenses and warrants issued to the placement agent.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Joseph Gunnar & Co., LLC | 24795 |
Source: Form D, filed Nov 22, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ryan M. Confer | Executive |
| David E. Friedman | Director |
| Bob Pearson | Director |
| Robert W. Pearson | Director |
| Julien Pham | Executive |
| John Rodney Varner | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1601 Trinity Street, Bldg. B, Ste 3322
Austin, TX, 78712
Austin, TX, 78712